Spyre Therapeutics
SYRE
SYRE
44 hedge funds and large institutions have $12M invested in Spyre Therapeutics in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
38% less capital invested
Capital invested by funds: $19.2M → $12M (-$7.21M)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Holders
44
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$176K | |
| 2 | +$69K | |
| 3 | +$59.6K | |
| 4 |
Jane Street
New York
|
+$12.4K |
| 5 |
Renaissance Technologies
New York
|
+$8.78K |
Top Sellers
| 1 | -$472K | |
| 2 | -$360K | |
| 3 | -$22.9K | |
| 4 |
HF
HRT Financial
New York
|
-$22K |
| 5 |
Two Sigma Investments
New York
|
-$21.2K |